In this full-day course, the morning sessions will address diagnostic challenges and medical management of epilepsy and its comorbidities across the lifespan. In the afternoon sessions, presentations will cover issues pertaining to surgical therapy in different age groups and a look into the future, where topics such as precision medicine and innovative imaging will be front and center.
The first quarter of the course will tackle diagnostic challenges across the lifespan. Imaging diagnostic challenges will be addressed by age group. Diagnostic distinctions between epilepsy and normal aging will be discussed, along with the diagnostic role of amplitude- integrated EEG in neonates. A debate will discuss pertinent issues in genetic testing in adults.
The second quarter of the course will tackle medical management of epilepsy and its comorbidities across the lifespan. The role of ketogenic diet in infancy will be reviewed, as well as the under-recognized sleep disorders in children. Psychiatric comorbidities will be discussed by age group and unique therapeutic considerations when using anti-seizure drugs in the elderly will be reviewed.
The third quarter of the course will elaborate on issues pertaining to surgical therapy in different age groups. Expanding indications in pediatrics and specific considerations in the elderly will be discussed. Tailoring therapy choices among the multiple available neuromodulatory options will be discussed. Finally, a debate will highlight specific risk/benefit considerations while considering the extent of resection in pediatric versus adult populations with epilepsy.
The course will conclude with a look into the future, where topics such as precision medicine and innovative imaging will be front and center. These innovations will be placed in the context of bringing appropriate epilepsy care to underserved communities by highlighting the barriers to care in global health. To wrap up, Dr. Mizrahi, President of the American Epilepsy Society, will provide a futuristic vision of the most needed future innovations in epilepsy.
Following participation in this activity, learners should be able to:
- Delineate the appropriate role of genetic testing and advanced neuroimaging in children, adults, and the elderly
- Recognize when genetic testing is appropriate in the work-up of epilepsy at all ages
- Recognize when specific advanced neuroimaging tests are indicated in the work-up of epilepsy at all ages
- Delineate the indications for amplitude integrated EEG in neonates
- Distinguish clinical signs that should raise the suspicion of epilepsy in the elderly population
- Delineate the most critical psychiatric co-morbidities to consider across the lifespan
- Be knowledgeable in the various considerations necessary prior to prescribing seizure medications in the elderly (metabolism, effectiveness profiles, interactions with other medications, among others)
- Recognize the warning signs of specific co- morbidities, mainly sleep disorders, in children with epilepsy
- Recognize and treat psychiatric co-morbidities across the lifespan in patients with epilepsy.
- Appropriately select candidates for epilepsy surgery in infancy
- Recognize indications and risks of epilepsy surgery in the elderly
- Delineate the distinctions among different neuromodulatory treatments (VNS, DBS, RNS)
- Discuss innovative minimally invasive surgical techniques such as laser and thermal ablation
- Conceptualize methods to incorporate innovative technology into daily practice
- Review and discuss the cutting-edge knowledge regarding diagnosis and treatment of people with epilepsy
- Identify barriers to care implementation and discuss strategies for overcoming said barriers
Neurologists, epileptologists, pediatric neurologists, nurses, psychologists/neuropsychologists, nurse practitioners/physician assistants, pharmacists
Registered Attendees have free access to 2017 meeting recordings. Contact email@example.com if you need the coupon code.